1. Home
  2. CRBP vs BIRD Comparison

CRBP vs BIRD Comparison

Compare CRBP & BIRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBP
  • BIRD
  • Stock Information
  • Founded
  • CRBP 2009
  • BIRD 2015
  • Country
  • CRBP United States
  • BIRD United States
  • Employees
  • CRBP N/A
  • BIRD N/A
  • Industry
  • CRBP Biotechnology: Pharmaceutical Preparations
  • BIRD Apparel
  • Sector
  • CRBP Health Care
  • BIRD Consumer Discretionary
  • Exchange
  • CRBP Nasdaq
  • BIRD Nasdaq
  • Market Cap
  • CRBP 96.5M
  • BIRD 99.0M
  • IPO Year
  • CRBP N/A
  • BIRD 2021
  • Fundamental
  • Price
  • CRBP $8.22
  • BIRD $12.16
  • Analyst Decision
  • CRBP Strong Buy
  • BIRD Buy
  • Analyst Count
  • CRBP 10
  • BIRD 2
  • Target Price
  • CRBP $53.56
  • BIRD $9.50
  • AVG Volume (30 Days)
  • CRBP 215.8K
  • BIRD 82.1K
  • Earning Date
  • CRBP 08-05-2025
  • BIRD 08-06-2025
  • Dividend Yield
  • CRBP N/A
  • BIRD N/A
  • EPS Growth
  • CRBP N/A
  • BIRD N/A
  • EPS
  • CRBP N/A
  • BIRD N/A
  • Revenue
  • CRBP N/A
  • BIRD $182,544,000.00
  • Revenue This Year
  • CRBP N/A
  • BIRD N/A
  • Revenue Next Year
  • CRBP $270.04
  • BIRD $5.16
  • P/E Ratio
  • CRBP N/A
  • BIRD N/A
  • Revenue Growth
  • CRBP N/A
  • BIRD N/A
  • 52 Week Low
  • CRBP $4.64
  • BIRD $3.93
  • 52 Week High
  • CRBP $61.90
  • BIRD $18.33
  • Technical
  • Relative Strength Index (RSI)
  • CRBP 54.23
  • BIRD 57.72
  • Support Level
  • CRBP $7.26
  • BIRD $10.10
  • Resistance Level
  • CRBP $7.90
  • BIRD $11.20
  • Average True Range (ATR)
  • CRBP 0.53
  • BIRD 0.84
  • MACD
  • CRBP -0.01
  • BIRD -0.11
  • Stochastic Oscillator
  • CRBP 78.59
  • BIRD 74.58

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About BIRD Allbirds Inc.

Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.

Share on Social Networks: